Lessons from the Tim Greenamyre model

• Laurie H. Sanders,
• Nancy Blechman,
• Sarah Berman,
• Erwan Bezard,
• Fabio Blandini,
• Jason Cannon,
• Mark Cookson,
• Briana De Miranda,
• Roberto Di Maio,
• Robert Drolet,
• Jim Greene,
• Jessica Kappel,
• Mark Kaufmann,
• Matthew Keeney,
• Arthur S. Levine,
• Abby Olsen,
• Teddy Pettus,
• Sean Pintchovski,
• Ian Reynolds,
• Emily Rocha,
• William Shrader,
• Valerie Suski,
• Malú Gámez Tansey,
• Anne Young,
• Pier Mastroberardino

Affiliations

Laurie H. Sanders

Departments of Neurology and Pathology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, USA

Nancy Blechman

Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Sarah Berman

Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Erwan Bezard

Univ. Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France; Corresponding authors at: Univ. Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France.

Fabio Blandini

IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan 20122, Italy; Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy

Jason Cannon

School of Health Sciences, Purdue University, West Lafayette, IN 47901, USA; Purdue Institute for Integrative Neuroscience, Purdue University, West Lafayette, IN 47901, USA

Mark Cookson

Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA

Briana De Miranda

Killion Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35924, USA

Roberto Di Maio

Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Robert Drolet

Neuroscience Department, Merck & Co., Inc., Rahway, NJ, United States of America

Jim Greene

Department of Neurology, Emory University, Atlanta, GA, USA

Jessica Kappel

Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Mark Kaufmann

Acurex Biosciences, San Carlos, CA, USA

Matthew Keeney

Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Arthur S. Levine

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Abby Olsen

Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Teddy Pettus

Department of Cell Biology, Emory University, Atlanta, GA, USA

Sean Pintchovski

Acurex Biosciences, San Carlos, CA, USA

Ian Reynolds

YaghPenn Consulting BV, 3061 Leefdaal, Belgium

Emily Rocha

Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

William Shrader

Acurex Biosciences, San Carlos, CA, USA

Valerie Suski

Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Malú Gámez Tansey

Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA

Anne Young

Massachusetts General Hospital, Boston, MA, USA

Pier Mastroberardino

Università degli Studi dell'Aquila, L'Aquila, Italy; Department of Molecular Genetics, Erasmus MC, Rotterdam, the Netherlands; Corresponding authors at: Univ. Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, France.